Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Cerecor’s antibody reduces respiratory failure in Covid-19 ARDS trial

pharmaceutical-technologyMarch 03, 2021

Tag: Cerecor , light , ARDS , CERC-002 , COVID-19

PharmaSources Customer Service